Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about CHI3L1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
CHI3L1 (Chitinase 3-like Protein 1), also known as YKL-40, is a secreted glycoprotein implicated in neuroinflammation and neurodegenerative diseases including Alzheimer's and Parkinson's.
No AI portrait yet
| Gene Symbol | CHI3L1 |
| Full Name | Chitinase 3-Like 1 |
| Aliases | Chitinase 3-like Protein 1 |
| Chromosome | 1q32.1 |
| Protein Type | Hydrolase |
| Function | CHI3L1 is a member of the glycosyl hydrolase family 18 but lacks enzymatic activity. |
| Primary Expression | hippocampus, cortex, and basal ganglia - Cell Types: Primarily microglia and astrocytes - |
| Molecular Weight | 40 kDa |
| Amino Acids | 383 aa |
| Pathways | NF-κB signaling |
| UniProt ID | P36222 |
| NCBI Gene ID | 1116 |
| Ensembl ID | ENSG00000133048 |
| GeneCards | CHI3L1 |
| Human Protein Atlas | CHI3L1 |
| Associated Diseases | Als, Alzheimer, Fibrosis, Inflammation, neurodegeneration |
| Known Drugs/Compounds | hygromycin B |
| Interactions | Actin, AGING, ALZHEIMER, ALZHEIMER'S DISEASE, AMYLOID, AMYOTROPHIC LATERAL SCLEROSIS |
| SciDEX Hypotheses | Integrated Biomarker Panel for Therapeutic Window |
| KG Connections | 359 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
CHI3L1["CHI3L1"]
CHI3L1 -->|"activates"| Neurodegeneration["Neurodegeneration"]
CHI3L1 -->|"expressed in"| Inflammation["Inflammation"]
CHI3L1 -->|"expressed in"| Neuroinflammation["Neuroinflammation"]
CHI3L1 -->|"contributes to"| Aging["Aging"]
CHI3L1 -->|"activates"| Autoimmune["Autoimmune"]
CHI3L1 -.biomarker for.-> Als["Als"]
CHI3L1 -.biomarker for.-> Alzheimer["Alzheimer"]
CHI3L1 -->|"regulates"| Glioblastoma["Glioblastoma"]
CHI3L1 -->|"inhibits"| Tumor["Tumor"]
STAT3["STAT3"] -->|"regulates"| CHI3L1
IL9["IL9"] -.biomarker for.-> CHI3L1
IL4["IL4"] -.biomarker for.-> CHI3L1
FGF2["FGF2"] -.biomarker for.-> CHI3L1
GFAP["GFAP"] -.biomarker for.-> CHI3L1
MDH1["MDH1"] -.biomarker for.-> CHI3L1
SQSTM1["SQSTM1"] -.biomarker for.-> CHI3L1
BDNF["BDNF"] -.biomarker for.-> CHI3L1
APOE["APOE"] -.biomarker for.-> CHI3L1
NEFL["NEFL"] -.biomarker for.-> CHI3L1| Target | Relation | Type | Str |
|---|---|---|---|
| STAT3 | binds_to | protein | 0.95 |
| Neuroinflammation | associated_with | process | 0.95 |
| YKL-40 | encodes | protein | 0.95 |
| Astrocytes | expressed_in | cell_type | 0.95 |
| Hippocampal Neurogenesis | inhibits | process | 0.95 |
| CRTH2 | binds | receptor | 0.90 |
| Neuromyelitis Optica | biomarker_for | disease | 0.90 |
| Neural Stem Cell Proliferation | inhibits | process | 0.90 |
| Neuronal Differentiation | inhibits | process | 0.90 |
| Alzheimer'S Disease | involved_in | disease | 0.90 |
| proneural-mesenchymal transition | promotes | process | 0.90 |
| Neuromyelitis Optica | biomarker_for | disease | 0.90 |
| Glial Activation | regulates | process | 0.90 |
| ASTROCYTE | secreted_by | cell_type | 0.90 |
| Cognitive Impairment | correlates_with | phenotype | 0.85 |
| Microglia | modulates | cell_type | 0.85 |
| Neuroinflammation | biomarker_for | process | 0.85 |
| Astrocyte Circadian Clock | associated_with | process | 0.85 |
| Amyloid Plaque Burden | modulates | phenotype | 0.85 |
| AD Progression | risk_factor_for | phenotype | 0.85 |
| macrophage phenotype | modulates | phenotype | 0.84 |
| Microglial Activation | modulates | process | 0.80 |
| Astrocyte Activation | regulates | process | 0.80 |
| neural stem cells | inhibits | cell_type | 0.80 |
| Glial Phagocytosis | inhibits | process | 0.75 |
| Neurodegeneration | activates | disease | 0.75 |
| Als | activates | disease | 0.75 |
| Autoimmune | activates | disease | 0.75 |
| Phagocytosis | suppresses | process | 0.75 |
| ASTROCYTES | activates | gene | 0.70 |
| astrocytes | expressed_in | cell_type | 0.70 |
| neurons | expressed_in | cell_type | 0.70 |
| stem cells | expressed_in | cell_type | 0.70 |
| hippocampus | expressed_in | brain_region | 0.70 |
| Inflammation | regulates | disease | 0.65 |
| Alzheimer | regulates | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Cardiovascular | therapeutic_target | disease | 0.65 |
| Neuroinflammation | regulates | disease | 0.65 |
| Multiple Sclerosis | activates | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Als | biomarker_for | disease | 0.65 |
| Senescence | expressed_in | disease | 0.65 |
| Diabetes | interacts_with | disease | 0.65 |
| Fibrosis | activates | disease | 0.65 |
| Neurodegeneration | biomarker_for | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Inflammation | associated_with | disease | 0.65 |
| Fibrosis | associated_with | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Astrocytes | expressed_in | cell_type | 0.95 |
| AQP4 | regulates | protein | 0.90 |
| AQP4 Autoantibodies | upregulates | compound | 0.90 |
| Astrocyte | product_of | cell_type | 0.90 |
| hygromycin B | inhibits | drug | 0.85 |
| STAT3 | interacts_with | gene | 0.80 |
| STAT3 | regulates | protein | 0.80 |
| AQP4 | activates | gene | 0.60 |
| SPP1 | regulates | gene | 0.60 |
| STAT3 | activates | gene | 0.60 |
| GBM | activates | gene | 0.60 |
| TAU | associated_with | gene | 0.60 |
| APP | inhibits | gene | 0.60 |
| AIF1 | biomarker_for | gene | 0.60 |
| C1QA | biomarker_for | gene | 0.60 |
| C1QB | biomarker_for | gene | 0.60 |
| C1QC | biomarker_for | gene | 0.60 |
| C1R | biomarker_for | gene | 0.60 |
| C1S | biomarker_for | gene | 0.60 |
| C3 | biomarker_for | gene | 0.60 |
| ASTROCYTES | activates | gene | 0.60 |
| ALZHEIMER | regulates | gene | 0.60 |
| APOPTOSIS | activates | gene | 0.60 |
| NEURODEGENERATION | activates | gene | 0.60 |
| PARKINSON'S DISEASE | activates | gene | 0.60 |
| PARKINSON | activates | gene | 0.60 |
| ALZHEIMER | activates | gene | 0.60 |
| CYTOKINES | activates | gene | 0.60 |
| ASTROCYTE | activates | gene | 0.60 |
| AND | inhibits | gene | 0.60 |
| AND | activates | gene | 0.60 |
| NEUROINFLAMMATION | expressed_in | gene | 0.60 |
| AGING | activates | gene | 0.60 |
| ASTROCYTE | regulates | gene | 0.60 |
| NEUROINFLAMMATION | regulates | gene | 0.60 |
| RNA | expressed_in | gene | 0.60 |
| APOE | biomarker_for | gene | 0.60 |
| NEFL | biomarker_for | gene | 0.60 |
| APOPTOSIS | interacts_with | gene | 0.60 |
| BDNF | biomarker_for | gene | 0.60 |
| IL-1 | inhibits | gene | 0.60 |
| EGF | therapeutic_target | gene | 0.60 |
| CD68 | inhibits | gene | 0.60 |
| CLOCK | regulates | gene | 0.60 |
| NEUROINFLAMMATION | associated_with | gene | 0.60 |
| ITGB1 | activates | gene | 0.60 |
| ASTROCYTES | inhibits | gene | 0.60 |
| IL-10 | activates | gene | 0.60 |
| RNA | activates | gene | 0.60 |
| ARG1 | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Integrated Biomarker Panel for Therapeutic Window Identifica | 0.784 | neurodegeneration | What are the precise temporal dynamics o |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.808
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Chi3l1 deletion effects on baseline glial activation in mice | validation | baseline neuroinflammation | 0.900 | 0.00 | Chi3l1 knockout mice | proposed | N/A |
| CHI3L1 variant association with AD progression in human patients | exploratory | Alzheimer's disease | 0.850 | 0.00 | human patients | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Monocyte LOXHD1 and RHOB Expression Predictive of Progressive Systemic Sclerosis [PMID:40771159] | Padilla CM, Lafyatis R, Gibson KF, Morse | Arthritis Care Res (Hoboken) | 2026 | 0 |
| Obstructive sleep apnea, biomarker profiles, and clinical progression in Parkins [PMID:41499940] | Zhu S, An D, Liu X | Sleep Med | 2026 | 0 |
| SuPAR levels are increased in sera of euthymic patients with bipolar disorder an [PMID:41605346] | Kök Kendirlioğlu B, Çörekli Kaymakçı E, | J Affect Disord | 2026 | 0 |
| Chitinase-like Proteins YKL-40 and YKL-39 in Colorectal Cancer. [PMID:41677627] | Ivanova T, Kazakova M, Dikov D, Dzhambov | Cells | 2026 | 0 |
| Correction: CHI3L1: An Emerging Player in Neuroinflammation and Neurodegeneratio [PMID:41699333] | Mushtaq Umar; Seh Bilal Ahmad; Khanday F | Molecular Neurobiology | 2026 | 0 |
| Association of Alzheimer's disease progression with YKL40 levels in peripheral b [PMID:41725729] | Yang Q, Wang R, Pei J, Fu Q, Zhan Y et a | Front Neurol | 2026 | 0 |
| Constitutive neuronal expression and disease-associated upregulation of chitinas [PMID:41762671] | Gaur N, Angerer C, Gunes ZI, Ancau M, Wa | Brain | 2026 | 0 |
| Plasma CHI3L1 as a marker of cognitive and structural brain changes in radiologi [PMID:41953284] | Schneider R, Brand-Arzamendi K, Lim TR, | BMJ Neurol Open | 2026 | 0 |
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning CHI3L1 in their description or question text
No additional research found